Lumos Pharma to Participate in the H.C. Wainwright BioConnect 2021 Conference

AUSTIN, Texas, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the company will participate in the virtual H.C. Wainwright BioConnect 2021 Conference to be held January 11-14, 2021.

Read the original here:
Lumos Pharma to Participate in the H.C. Wainwright BioConnect 2021 Conference

Related Post